Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.

Cynata Therapeutics advances stem cell trials with strong financial position in March 2025 quarter

Pallavi Madhiraju- April 27, 2025 0

Find out how Cynata Therapeutics is driving innovation in regenerative medicine while maintaining a strong financial runway into 2026! Read More

Aurobindo Pharma’s CuraTeQ Biologics set for major breakthrough as CHMP backs Dazublys cancer biosimilar

Pallavi Madhiraju- April 27, 2025 0

CuraTeQ Biologics secures CHMP positive opinion for Dazublys, boosting Aurobindo Pharma’s biosimilar ambitions. Find out how it’s shaping the future of cancer care! Read More

VERAXA Biotech seals $1.64bn SPAC merger to launch Nasdaq oncology powerhouse

Pallavi Madhiraju- April 25, 2025 0

Find out how VERAXA Biotech’s $1.64B Nasdaq listing is set to redefine cancer treatment with next-gen antibody therapies. Read More

Game-changer for knee pain? Sun Pharma’s MM-II injection delivers lasting relief, wins FDA fast track

Pallavi Madhiraju- April 24, 2025 0

Sun Pharma and Moebius report breakthrough in knee osteoarthritis treatment with MM-II. Learn how this new therapy could reshape pain management. Read More

Eli Lilly’s oral weight-loss pill shakes Novo Nordisk as investors brace for market shift

Pallavi Madhiraju- April 23, 2025 0

Novo Nordisk shares drop after Eli Lilly’s oral weight-loss pill shows promise. Analysts see a shifting obesity drug market. What this means for investors. Read More

Roche bets big on America: $50bn to fuel next-gen weight loss drugs and diagnostics boom

Pallavi Madhiraju- April 23, 2025 0

Discover how Roche’s $50 billion U.S. investment is transforming pharma R&D, diagnostics, and job creation across eight states and reshaping global exports. Read More

ACIP expands Pfizer’s ABRYSVO vaccine guidance to include at-risk adults aged 50–59

Pallavi Madhiraju- April 21, 2025 0

Pfizer's RSV vaccine ABRYSVO now recommended for at-risk adults aged 50–59. Learn what it means for public health and Pfizer’s expanding vaccine portfolio. Read More

Lilly’s oral GLP-1 pill cuts blood sugar and weight without injections—Here’s what the breakthrough data shows

Pallavi Madhiraju- April 21, 2025 0

Lilly’s oral GLP-1 drug orforglipron showed strong A1C and weight loss results in Phase 3—find out how it could change diabetes care worldwide. Read More

Lupin receives US FDA nod for Nagpur injectable facility manufacturing drug-device combinations

Pallavi Madhiraju- April 20, 2025 0

Lupin secures US FDA EIR for its Nagpur injectables facility, boosting export potential and complex generics expansion. Read how this impacts global strategy. Read More

Sigachi Industries secures green signal for massive Dahej SEZ project—3,120 MT/month pharma push begins now

Pallavi Madhiraju- April 20, 2025 0

Find out how Sigachi Industries is scaling its pharma manufacturing with a new Dahej SEZ facility cleared for construction. Read More

12345...27330 / 2730 Posts